Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Striving to become more patient-centric?

    August 25, 2020 |  

    Explore more with OPEN Health

    Patients are increasingly involved in their healthcare decisions. They have become empowered and informed data-driven advocates for their own health. We are currently at a tipping point in the industry as regulatory bodies and patient advocacy groups have come together to reinforce the importance of the role of patients in the drug development process.

    Why now?

    • Patient engagement tools have evolved considerably
    • There is an increased role of patients in regulatory and health technology decision making
    • Healthcare players who are unable or unwilling to deepen collaborations in the industry may find it difficult, if not impossible, to participate in a future patient-driven healthcare system

    But how does a patient-centric approach evolve from a one-off engagement tactic to a fully integrated, company-wide practice?

    Join us and take an interactive tour through today’s modern approach to patient-centricity. We will show how patient-centricity can be integrated into all phases of development and commercialization and show examples of how to achieve patient buy-in and ensure the patient voice is represented in your study outcomes.

    Start Your Journey

    In this interactive journey, you will:

    • Learn about the value of a patient-centric approach
    • Explore areas to focus on at different phases of the product life cycle
    • See real-life case studies of how a patient-centric approach can be used in therapeutic areas such as oncology, rare disease and advanced therapies
    • Find out how to take your first step to a patient-centric approach
    • Meet our team of experts and what drives them

    Pink divider

    Pharmerit – an OPEN Health Company has been at the forefront of the evolution of patient-centricity. We have seen the positive impact of engaging patients throughout the product lifecycle. We believe it is important to include patient-centricity in every project we undertake, combining expertise with outcomes to see the impact of co-creation.

    This content was provided by OPEN Health

    Company Details

    OPEN Health

    OPEN Health

    Email
    Website

     Latest Content from  OPEN Health 

    OPEN Health’s Learning & Development team have won a Bronze Award at the PM Society Digital Awards 2020

    We are delighted to have won a Bronze Award at the PM Society Digital Awards 2020 for  Excellence in Innovation: Immunology Training Summit.READ MORE ABOUT OUR WINNING PROJECT WITH WITH JANSSEN BELOW:The Immunology...

    OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020

    We are delighted to have won a Bronze Award at the PM Society Digital Awards 2020 for Effectiveness: Market Access.READ MORE ABOUT OUR WINNING PROJECT “VAGUS NERVE STIMULATION - ADDRESSING INEQUALITY...

    Meet OPEN Health and Pharmerit Experts at the World Pharma Pricing Market Access and Evidence Congress 2020

    Join OPEN Health and Pharmerit – an OPEN Health Company at the World Pharma Pricing Market Access and Evidence Congress from 23 – 25 September 2020, as we present:ROUNDTABLE: Wednesday, September 23,...

    Reflections of a Fireside Chat from the World Orphan Drug Congress 2020

    Hear from Trish Shepherd COO, Patient & Brand Communications, OPEN Health

    OPEN Health has been awarded a Bronze Medal by EcoVadis

    We are delighted to announce that OPEN Health has been awarded a Bronze Medal by EcoVadis for its very first Corporate Social Responsibility assessment in recognition of its commitment to Corporate Social...

    Digital Therapeutics Landscape in Europe

    OPEN Health introduce an overview of regulatory and HTA developments for digital therapeutics in Europe focusing on Germany and the UK

    OPEN Health’s virtual reflections on the World Orphan Drug Congress US

    Another congress attended in this virtual world with learnings gathered and connections made across the rare disease community. It was great to be joined by many colleagues from all our...

    A day in the life of the Global Head of Publications

    We asked Mina Patel to give us an insight into her role as Global Head of Publications at OPEN Health

    Striving to become more patient-centric?

    Explore more with OPEN Health

    Meet OPEN Health and Pharmerit Experts at the World Orphan Drug Virtual USA Congress

    Join OPEN Health and Pharmerit – an OPEN Health Company at the World Orphan Drug Virtual Congress from August 24-27, 2020, as we present:Advanced Therapies Commercial: Tuesday, August 25Succeeding with Star Wars...